Similarly, cancer-related markers, such as ROR1 or EpCAM, which are overexpressed in PCa, but also in other carcinomas such as colon cancer, were not able to distinguish between the benign and malignant changes in the prostate [37]. This evidence concerns the gene ROR1 and posterior cortical atrophy.